502 related articles for article (PubMed ID: 18465132)
1. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
Liu X; Chan SY; Ho PC
Cancer Chemother Pharmacol; 2008 Dec; 63(1):167-74. PubMed ID: 18465132
[TBL] [Abstract][Full Text] [Related]
2. Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity.
Chao WW; Cheng YW; Chen YR; Lee SH; Chiou CY; Shyur LF
Phytomedicine; 2019 Mar; 56():194-206. PubMed ID: 30668340
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
Salinas-Jazmín N; de la Fuente M; Jaimez R; Pérez-Tapia M; Pérez-Torres A; Velasco-Velázquez MA
Cancer Chemother Pharmacol; 2010 Apr; 65(5):931-40. PubMed ID: 19690859
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
Humphries MJ; Yamada KM; Olden K
J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines.
Majewski S; Szmurlo A; Marczak M; Jablonska S; Bollag W
Int J Cancer; 1994 Apr; 57(1):81-5. PubMed ID: 7512078
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of tumor invasion and metastasis by retinoid 4-APR].
Shi B; Li LM; You SQ; Xu SP; Han R
Yao Xue Xue Bao; 1997; 32(1):33-7. PubMed ID: 11243215
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of metastatic potential of B16-F10 melanoma cell line in vivo and in vitro by biflorin.
Andrade Carvalho A; da Costa PM; Da Silva Souza LG; Lemos TL; Alves AP; Pessoa C; de Moraes MO
Life Sci; 2013 Aug; 93(5-6):201-7. PubMed ID: 23743169
[TBL] [Abstract][Full Text] [Related]
8. Combination of anti-cell adhesive synthetic Arg-Gly-Asp-Ser analogue and anticancer drug doxorubicin heightens their original antimetastatic activities.
Komazawa H; Fujii H; Kojima M; Mori H; Ono M; Itoh I; Azuma I; Saiki I
Oncol Res; 1995; 7(7-8):341-51. PubMed ID: 8747597
[TBL] [Abstract][Full Text] [Related]
9. Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model.
Shi H; Wu Y; Wang Y; Zhou M; Yan S; Chen Z; Gu D; Cai Y
Nutr Cancer; 2015; 67(5):761-70. PubMed ID: 25978595
[TBL] [Abstract][Full Text] [Related]
10. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
13. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
[TBL] [Abstract][Full Text] [Related]
14. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
15. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells.
Chen J; Peng H; Ou-Yang X; He X
Melanoma Res; 2008 Oct; 18(5):322-9. PubMed ID: 18781130
[TBL] [Abstract][Full Text] [Related]
16. Improved treatment of disseminated B16f10 melanoma in mice with anticancer drugs in combination with L-histidinol.
Warrington RC; Fang WD
Anticancer Res; 1991; 11(5):1869-74. PubMed ID: 1722659
[TBL] [Abstract][Full Text] [Related]
17. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy.
Entin I; Plotnikov A; Korenstein R; Keisari Y
Clin Cancer Res; 2003 Aug; 9(8):3190-7. PubMed ID: 12912972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
